Osteomyelitis is the name for a bone infection. It is an inflammatory condition that affects the bone as well as its supporting tissues and can be acute or long-term. Pyogenic organisms that cause it, including mycobacteria, bacteria, and fungus, were the source of the infection. It’s interesting to note that bone infections have been found in animal fossils from archaeological sites, indicating that this illness is comparatively old.
Before Nelaton coined the term osteomyelitis in 1844, other terms were used over the decades to characterize infected bones. The primary surgical treatment for osteomyelitis prior to the invention of penicillin throughout the 1940s included severe debridement, wound healing, and saucerization.
The afflicted area was then left to recover by secondary intention, which resulted in a high sepsis death rate. The fatality rates from osteomyelitis, especially staphylococcus osteomyelitis, have considerably decreased since antibiotics were widely available.
Epidemiology
Although the overall prevalence of osteomyelitis in the US is mostly unclear, statistics indicate that there are as many as 50,000 instances per year or 1 in 675 hospitalizations in the US. According to other research, there are 21.8 incidences of osteomyelitis overall for every 100,000 individuals.
The frequency was higher in men for unknown reasons, although it rises with age, primarily because concomitant conditions, including peripheral vascular conditions and diabetes mellitus, are more common.
Additionally, the accessibility of sensitive imaging tests like bone scintigraphy and MRI (magnetic resonance imaging) has increased diagnostic precision and the capacity to describe the infection.
Anatomy
Pathophysiology
The hematogenous pathway of infection can cause the bone to become infected through direct injection from surgery or trauma, contiguous dissemination from nearby joints and tissues, or bacteremic seeding of bone from a distant source of infection. In comparison to adults, children experience hematogenous osteomyelitis more commonly, and lengthy bones are typically affected.
Hematogenous osteomyelitis most frequently impacts the vertebrae in adulthood. While adjoining osteomyelitis mainly affects young adults following trauma and associated surgery, it typically affects elderly adults following decubitus blisters and infectious bone arthroplasties. The presence of underlining diabetes complications commonly results in osteomyelitis linked to vascular dysfunction.
Osteomyelitis frequently develops in diabetic people as a result of reduced blood flow to the lower extremities, which also affects local defense mechanisms and dermal regeneration, facilitating the infection to spread. Making matters worse, sensory neuropathy in the presence of diabetes mellitus predisposes the development of skin ulcers at trauma and pressure locations.
Patients who are wheelchair- or bed-bound and vulnerable to pressure-related dermal bleeding ulcers, particularly in the heel, hips, sacrum, and buttock, commonly develop adjoining osteomyelitis. As a result of the polymicrobial fauna from the gastrointestinal and skin frequently colonizing these ulcers, soft tissue infectious disease can easily move to the underlining bone.
Soft tissue and trauma resulting in infected, bare skin are additional origins of adjoining osteomyelitis. In the presence of fractures, during bone repair surgery, or after the implantation of orthopedic hardware, osteomyelitis caused by direct bacterial inoculation might develop.
Etiology
Intact, healthy bone is infection resistant. A large bacterial inoculum, ischemia, trauma, or the presence of foreign bodies all increase the susceptibility of the bone to disease by exposing bone locations that microorganisms can attach to. Staphylococcus aureus and other bacteria express adhesins, which are receptors for certain fibronectin collagen, bone sialoglycoprotein, and laminin components of the bone matrix.
Staphylococcus aureus has a collagen-binding strain that allows it to adhere to osteo cartilage, and it has recently been found that the fibronectin-binding adhesin plays a role in bacterial adhesion to medically implants in bone. It’s also noteworthy that S. aureus, after being taken up by cultivated osteoblasts, can survive intracellularly.
Some bacteria cover themselves and the surfaces beneath them with a biofilm layer of protection. The persistence of bone infections and high failure rates of shorter courses of antimicrobial therapy may be explained by some bacteria’s capacity to cling to the bone and surgically implanted devices, after which they show phenotypic resistance to antibiotic therapy.
Genetics
Prognostic Factors
Acute osteomyelitis has an excellent prognosis with strong early treatment. Years after a successful course of treatment, the infection may return if the same location experiences fresh stress or if the host’s immunity is weakened. At twelve months, chronic osteomyelitis in humans has a recurrence incidence of about 30 percent, but in P. aeruginosa cases, the risk of recurrence can reach 50 percent.
Treatment is more challenging in cases requiring prosthetic implants, which enhances morbidity since it necessitates more surgeries and requires longer antibiotic treatments. When possible, thorough preoperative planning is performed together with the utilization of operating rooms with laminar airflow to prevent postoperative infections.
Additionally advised is the use of prophylactic preoperative antibiotic therapy given parenterally 30 minutes prior to skin incision with first- (cefazolin) or second-generation cephalosporins (cefuroxime). All of these actions have been demonstrated to improve patient outcomes by reducing the rate of postoperative infections from 0.5 percent to 2 percent.
1-2 g IV or IM every 12hrs for moderate infections
2 g IV every 12hrs for Severe infections
3 g IV every 12hrs for Life-threatening infections
The maximum duration of therapy is 3-4 weeks
1-2 g IV or IM was given once a day or in equally divided doses 2x a day
maximum duration of therapy is 4-14 days
prolonged treatment recommends for complicated infections
At least treatment given ten days for diseases due to streptococcus
Osteomyelitis is the name for a bone infection. It is an inflammatory condition that affects the bone as well as its supporting tissues and can be acute or long-term. Pyogenic organisms that cause it, including mycobacteria, bacteria, and fungus, were the source of the infection. It’s interesting to note that bone infections have been found in animal fossils from archaeological sites, indicating that this illness is comparatively old.
Before Nelaton coined the term osteomyelitis in 1844, other terms were used over the decades to characterize infected bones. The primary surgical treatment for osteomyelitis prior to the invention of penicillin throughout the 1940s included severe debridement, wound healing, and saucerization.
The afflicted area was then left to recover by secondary intention, which resulted in a high sepsis death rate. The fatality rates from osteomyelitis, especially staphylococcus osteomyelitis, have considerably decreased since antibiotics were widely available.
Although the overall prevalence of osteomyelitis in the US is mostly unclear, statistics indicate that there are as many as 50,000 instances per year or 1 in 675 hospitalizations in the US. According to other research, there are 21.8 incidences of osteomyelitis overall for every 100,000 individuals.
The frequency was higher in men for unknown reasons, although it rises with age, primarily because concomitant conditions, including peripheral vascular conditions and diabetes mellitus, are more common.
Additionally, the accessibility of sensitive imaging tests like bone scintigraphy and MRI (magnetic resonance imaging) has increased diagnostic precision and the capacity to describe the infection.
The hematogenous pathway of infection can cause the bone to become infected through direct injection from surgery or trauma, contiguous dissemination from nearby joints and tissues, or bacteremic seeding of bone from a distant source of infection. In comparison to adults, children experience hematogenous osteomyelitis more commonly, and lengthy bones are typically affected.
Hematogenous osteomyelitis most frequently impacts the vertebrae in adulthood. While adjoining osteomyelitis mainly affects young adults following trauma and associated surgery, it typically affects elderly adults following decubitus blisters and infectious bone arthroplasties. The presence of underlining diabetes complications commonly results in osteomyelitis linked to vascular dysfunction.
Osteomyelitis frequently develops in diabetic people as a result of reduced blood flow to the lower extremities, which also affects local defense mechanisms and dermal regeneration, facilitating the infection to spread. Making matters worse, sensory neuropathy in the presence of diabetes mellitus predisposes the development of skin ulcers at trauma and pressure locations.
Patients who are wheelchair- or bed-bound and vulnerable to pressure-related dermal bleeding ulcers, particularly in the heel, hips, sacrum, and buttock, commonly develop adjoining osteomyelitis. As a result of the polymicrobial fauna from the gastrointestinal and skin frequently colonizing these ulcers, soft tissue infectious disease can easily move to the underlining bone.
Soft tissue and trauma resulting in infected, bare skin are additional origins of adjoining osteomyelitis. In the presence of fractures, during bone repair surgery, or after the implantation of orthopedic hardware, osteomyelitis caused by direct bacterial inoculation might develop.
Intact, healthy bone is infection resistant. A large bacterial inoculum, ischemia, trauma, or the presence of foreign bodies all increase the susceptibility of the bone to disease by exposing bone locations that microorganisms can attach to. Staphylococcus aureus and other bacteria express adhesins, which are receptors for certain fibronectin collagen, bone sialoglycoprotein, and laminin components of the bone matrix.
Staphylococcus aureus has a collagen-binding strain that allows it to adhere to osteo cartilage, and it has recently been found that the fibronectin-binding adhesin plays a role in bacterial adhesion to medically implants in bone. It’s also noteworthy that S. aureus, after being taken up by cultivated osteoblasts, can survive intracellularly.
Some bacteria cover themselves and the surfaces beneath them with a biofilm layer of protection. The persistence of bone infections and high failure rates of shorter courses of antimicrobial therapy may be explained by some bacteria’s capacity to cling to the bone and surgically implanted devices, after which they show phenotypic resistance to antibiotic therapy.
Acute osteomyelitis has an excellent prognosis with strong early treatment. Years after a successful course of treatment, the infection may return if the same location experiences fresh stress or if the host’s immunity is weakened. At twelve months, chronic osteomyelitis in humans has a recurrence incidence of about 30 percent, but in P. aeruginosa cases, the risk of recurrence can reach 50 percent.
Treatment is more challenging in cases requiring prosthetic implants, which enhances morbidity since it necessitates more surgeries and requires longer antibiotic treatments. When possible, thorough preoperative planning is performed together with the utilization of operating rooms with laminar airflow to prevent postoperative infections.
Additionally advised is the use of prophylactic preoperative antibiotic therapy given parenterally 30 minutes prior to skin incision with first- (cefazolin) or second-generation cephalosporins (cefuroxime). All of these actions have been demonstrated to improve patient outcomes by reducing the rate of postoperative infections from 0.5 percent to 2 percent.
1-2 g IV or IM every 12hrs for moderate infections
2 g IV every 12hrs for Severe infections
3 g IV every 12hrs for Life-threatening infections
The maximum duration of therapy is 3-4 weeks
1-2 g IV or IM was given once a day or in equally divided doses 2x a day
maximum duration of therapy is 4-14 days
prolonged treatment recommends for complicated infections
At least treatment given ten days for diseases due to streptococcus
moderate infections:
1-2g intramuscular or intravenous every 8 to 12 hours
severe infections:
2g intravenous every 6 to 8 hours
Dose Adjustments
Renal impairment
If a patient's CrCl is between 10-30 mL/min, a loading dose of 1-2 g is recommended, followed by 50% of the usual dosage
If the CrCl is below 10 mL/min, a 1-2 g loading dose is recommended, followed by 25% of the usual dosage
https://www.ncbi.nlm.nih.gov/books/NBK532250/
medtigo
Osteomyelitis
Updated :
August 17, 2023
Osteomyelitis is the name for a bone infection. It is an inflammatory condition that affects the bone as well as its supporting tissues and can be acute or long-term. Pyogenic organisms that cause it, including mycobacteria, bacteria, and fungus, were the source of the infection. It’s interesting to note that bone infections have been found in animal fossils from archaeological sites, indicating that this illness is comparatively old.
Before Nelaton coined the term osteomyelitis in 1844, other terms were used over the decades to characterize infected bones. The primary surgical treatment for osteomyelitis prior to the invention of penicillin throughout the 1940s included severe debridement, wound healing, and saucerization.
The afflicted area was then left to recover by secondary intention, which resulted in a high sepsis death rate. The fatality rates from osteomyelitis, especially staphylococcus osteomyelitis, have considerably decreased since antibiotics were widely available.
Although the overall prevalence of osteomyelitis in the US is mostly unclear, statistics indicate that there are as many as 50,000 instances per year or 1 in 675 hospitalizations in the US. According to other research, there are 21.8 incidences of osteomyelitis overall for every 100,000 individuals.
The frequency was higher in men for unknown reasons, although it rises with age, primarily because concomitant conditions, including peripheral vascular conditions and diabetes mellitus, are more common.
Additionally, the accessibility of sensitive imaging tests like bone scintigraphy and MRI (magnetic resonance imaging) has increased diagnostic precision and the capacity to describe the infection.
The hematogenous pathway of infection can cause the bone to become infected through direct injection from surgery or trauma, contiguous dissemination from nearby joints and tissues, or bacteremic seeding of bone from a distant source of infection. In comparison to adults, children experience hematogenous osteomyelitis more commonly, and lengthy bones are typically affected.
Hematogenous osteomyelitis most frequently impacts the vertebrae in adulthood. While adjoining osteomyelitis mainly affects young adults following trauma and associated surgery, it typically affects elderly adults following decubitus blisters and infectious bone arthroplasties. The presence of underlining diabetes complications commonly results in osteomyelitis linked to vascular dysfunction.
Osteomyelitis frequently develops in diabetic people as a result of reduced blood flow to the lower extremities, which also affects local defense mechanisms and dermal regeneration, facilitating the infection to spread. Making matters worse, sensory neuropathy in the presence of diabetes mellitus predisposes the development of skin ulcers at trauma and pressure locations.
Patients who are wheelchair- or bed-bound and vulnerable to pressure-related dermal bleeding ulcers, particularly in the heel, hips, sacrum, and buttock, commonly develop adjoining osteomyelitis. As a result of the polymicrobial fauna from the gastrointestinal and skin frequently colonizing these ulcers, soft tissue infectious disease can easily move to the underlining bone.
Soft tissue and trauma resulting in infected, bare skin are additional origins of adjoining osteomyelitis. In the presence of fractures, during bone repair surgery, or after the implantation of orthopedic hardware, osteomyelitis caused by direct bacterial inoculation might develop.
Intact, healthy bone is infection resistant. A large bacterial inoculum, ischemia, trauma, or the presence of foreign bodies all increase the susceptibility of the bone to disease by exposing bone locations that microorganisms can attach to. Staphylococcus aureus and other bacteria express adhesins, which are receptors for certain fibronectin collagen, bone sialoglycoprotein, and laminin components of the bone matrix.
Staphylococcus aureus has a collagen-binding strain that allows it to adhere to osteo cartilage, and it has recently been found that the fibronectin-binding adhesin plays a role in bacterial adhesion to medically implants in bone. It’s also noteworthy that S. aureus, after being taken up by cultivated osteoblasts, can survive intracellularly.
Some bacteria cover themselves and the surfaces beneath them with a biofilm layer of protection. The persistence of bone infections and high failure rates of shorter courses of antimicrobial therapy may be explained by some bacteria’s capacity to cling to the bone and surgically implanted devices, after which they show phenotypic resistance to antibiotic therapy.
Acute osteomyelitis has an excellent prognosis with strong early treatment. Years after a successful course of treatment, the infection may return if the same location experiences fresh stress or if the host’s immunity is weakened. At twelve months, chronic osteomyelitis in humans has a recurrence incidence of about 30 percent, but in P. aeruginosa cases, the risk of recurrence can reach 50 percent.
Treatment is more challenging in cases requiring prosthetic implants, which enhances morbidity since it necessitates more surgeries and requires longer antibiotic treatments. When possible, thorough preoperative planning is performed together with the utilization of operating rooms with laminar airflow to prevent postoperative infections.
Additionally advised is the use of prophylactic preoperative antibiotic therapy given parenterally 30 minutes prior to skin incision with first- (cefazolin) or second-generation cephalosporins (cefuroxime). All of these actions have been demonstrated to improve patient outcomes by reducing the rate of postoperative infections from 0.5 percent to 2 percent.
https://www.ncbi.nlm.nih.gov/books/NBK532250/
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
